A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: n n n n n n n n n n wherein R 1 , R 2 , R 3 , R 4 , R 5 , and n are as defined herein.